Market Signal Briefing

U.S. XRP spot ETFs just bought $38M worth of XRP — a strong sign institutions are positioning early for a potential breakout.

Cardano’s ADA price is currently trading near $0.43 on Binance, sitting just under short‑term resistance around $0.45 while intraday support clusters near $0.42–$0.40. The structure favors a choppy, leveraged range with a slight downside skew into late December unless bulls reclaim $0.45–$0.47 on convincing volume.​

Summary

ADA is currently trading below major MAs, stuck between $0.38 support and $0.48 resistance with derivatives driving much of the action.​
Recent network turbulence and the upcoming Midnight launch are currently shaping sentiment, keeping investors cautious but engaged.​
A decisive move above $0.45–$0.47 could currently unlock $0.50–$0.60, while a loss of $0.38 risks a slide into the mid‑$0.30s.

Market structure and levels
Cardano price (ADA) is currently trading in a broad downtrend from the 2025 high near $1.32 and remains over 80% below its all‑time high around $3. Price is compressing between local support at $0.40–$0.39 and resistance at $0.45–$0.47, with many desks watching a wider $0.38–$0.48 December range.​

Liquidity is concentrated in derivatives; open interest is elevated and short‑term traders are dominating flows, which amplifies fake breakouts around intraday levels. Spot volume is decent but not aggressive, signaling that real accumulation is still cautious rather than euphoric.​

Technicals and momentum
On higher timeframes, ADA is currently trading below key moving averages, confirming a macro downtrend despite periodic short squeezes. RSI recently bounced from oversold territory near 30, which creates room for a reflex rally but does not invalidate the bearish structure on its own.​

Short‑term traders are currently watching $0.423–$0.426 as immediate support and the $0.446–$0.47 area as a resistance ceiling capped by the 200‑EMA. A daily close above $0.45–$0.47 would likely open a run toward $0.50–$0.53, while a clean break below $0.40 exposes the mid‑$0.30s.​

News, sentiment, and flows
Three recent headlines frame sentiment:

Cardano’s Midnight privacy sidechain is currently heading for mainnet, and ADA is trading near $0.42 after sliding from a $1.32 YTD high as the launch approaches.​
A brief network disruption and a chain split event in late November pushed ADA down toward $0.38 and reinforced the market’s “show me” stance on reliability.​
A 70 million ADA treasury allocation for ecosystem growth highlights that insiders are still funding infrastructure, even as price grinds lower.​

Derivatives data shows persistent leveraged positioning and rising short interest, which keeps downside pressure alive but also loads the spring for occasional violent squeezes. Macro crypto sentiment is currently fragile but improving from November’s washout, and Cardano tends to lag rotations, which suits patient contrarians.​

30–60 day price outlook
Base case: ADA is currently trading in a sideways‑to‑slightly‑bearish range between $0.38 and $0.48 into early 2026 as leverage churns and spot buyers wait for cleaner confirmation of network stability after the recent incidents. An upside scenario requires a sustained break and daily close above $0.45–$0.47, then $0.50, backed by increasing spot volume and calmer derivatives funding; in that case, price is currently eyeing $0.55–$0.60 as a realistic target, not a moonshot.​

The bear scenario becomes dominant if ADA is currently losing the $0.38–$0.40 support band on heavy volume, which would likely drag price into the $0.33–$0.35 area where higher‑timeframe trendline support and prior demand converge. In other words, this is currently a trader’s market, not an investor’s victory lap; entries near $0.40 with tight invalidation and scaled profit‑taking into $0.47–$0.50 respect the chart and the fact that ADA still behaves like a high‑beta, sentiment‑driven L1 rather than a safe blue chip.

Despite the recent altcoin downturn, one analyst believes a major indicator is flashing green and could kickstart a major bull run. Ash Crypto, the analyst in question, has over 2 million followers on X (formerly Twitter), and he believes the altseason is right around the corner after the Russel 2000, a US-based small-cap market-cap index, hit new highs recently.

The influencer tweeted:

“Russell 2000 is the biggest indicator for Altseason, and it’s about to hit a new all-time high.

Same Cycle, Same Breakout Point

– Both Russell 2000 and ALTS MCAP peaked in Nov 2021, marking the cycle top.

Advertisement
 

– Both entered a long bear market (2022–2023).

 – Now, Russell is retesting its Nov 2021 highs, a key resistance zone.

– A breakout above these levels confirms the start of a major bull run in 2026.

History shows that the US Alts market (Russell 2000) and crypto ALTS often move in sync. If Russell breaks out, ETH and alts will follow it.

The crypto market is in a state of fear following the 10/10 flash crash, and all leverage is flushed, which means it’s a perfect scenario for a parabolic pump to start.

Must keep an eye on Russell as it will give an idea of how alts will move in the coming weeks.”

Image Source: X
According to this graph, Ash Crypto is trying to show the similarity between the price trends of altcoins and the Russel 2000 and argue that the latter is a major signal of an incoming altseason. According to reports, there has been a 0.75 annual correlation between the Russell 2000 and altcoins since early 2024. 

What is the Russel 2000?
The Russell 2000 is a market-cap-based index that details the performance of approximately 2,000 small-cap companies in the U.S. equity market. It is opposed to the regular stock market, which hosts some of the world’s largest publicly traded companies, aka blue-chip companies. In essence, it is an index that has historically attracted blue-collar workers seeking to capitalize on its volatility. 

Liquidity plays a major role in the performance of the Russel 2000 index, which has seen a sharp spike in the second half of the current calendar year due to the ongoing QT relaxation. Currently, it is hovering around its ATH above 2500 points, a roughly 17% increase since June 11. The index is poised to go ballistic, and cryptos like Solana, XRP, BNB, and others could follow suit immediately. 

The Russel 2000 index represents the stock market in the same way altcoins represent the larger cryptocurrency market. The small-cap digital currencies are more volatile and are made up of thousands of smaller projects, just like the Russel index. 

The Future
So, when the Russel 2000 records a new ATH due to improving liquidity, analysts believe that the similarly positioned altcoins are also in for a major price rebound. 2025 has been a massive disappointment for an overwhelming number of these smaller coin projects, so traders are waiting for a major bullish activity in 2026 and looking for clues regarding it. Ash Crypto believes the Russel 2000 is the biggest such indicator out there, and the altcoin market is right around the corner.

Share

Stablecoins

Circle has strengthened its global footprint by obtaining a full Financial Services Permission (FSP) license from the Financial Services Regulatory Authority of the Abu Dhabi Global Market.

The approval marks a major milestone for the company and reinforces Abu Dhabi’s ambition to lead regulated digital finance in the region.

A Regulated Base For USDC Adoption In The UAE
The new license officially recognizes Circle as a supervised money services provider within ADGM. This status gives the company the regulatory certainty needed to expand USDC into payments, settlements, and digital financial infrastructure across the United Arab Emirates. Firms operating under ADGM must meet strict standards for compliance, transparency, and consumer protection.

These requirements align closely with the region’s long-term strategy to attract global financial institutions. With a clear framework in place, banks, fintech developers, and corporate partners in the UAE can now integrate USDC with greater confidence. This shift may accelerate new settlement systems, faster cross-border transfers, and more efficient onchain financial services.

Leadership Moves And Regional Partnerships Support Expansion
Circle has appointed Dr. Saeeda Jaffar as Managing Director for the Middle East and Africa. Her leadership experience at Visa, where she served as Senior Vice President and Group Country Manager for the GCC, highlights Circle’s commitment to operating at a high institutional level in the region. Her expertise also positions Circle to engage closely with regulators, payment networks, and financial institutions.

This license also builds on earlier progress. The company secured in-principle approval in April 2025, giving it a head start on regulatory alignment. Circle has also partnered with Lulu Financial Holdings to modernize remittances and cross-border payment rails. The UAE is one of the world’s busiest remittance hubs, making it a strategic environment for USDC-powered financial innovation.

A Strategic Move With Regional Impact
Circle’s approval signals a broader shift toward regulated digital assets in the Middle East. USDC now has a clear pathway to support institutional payment solutions, corporate transactions, and emerging onchain financial tools. The license positions Circle to help shape the next stage of financial modernization across the UAE, Africa, and neighboring markets.

Author

Alexander Zdravkov

Reporter at CoinsPress

Alexander Zdravkov interessiert sich leidenschaftlich für Bedeutungsfragen. Er ist seit mehr als drei Jahren im Kryptobereich tätig und hat ein Auge dafür, aufkommende Trends in der Welt der digitalen Währungen aufzuspüren. Ob er nun tiefgreifende Analysen liefert oder tagesaktuell über alle Themen berichtet, sein tiefes Verständnis und seine Begeisterung für das, was er tut, macht ihn zu einer wertvollen Ergänzung für das CoinsPress-Team.

About Oliver Haill
Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup News Service, Gracenote... Read more

About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.

Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.

We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.

The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.

Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.

Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.

Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.

Watches of Switzerland remains a Buy, with a $9.5 price target, reflecting resilient H1 FY26 results and undervaluation. WOSGF's business model is underpinned by exclusive brand partnerships, especially with Rolex, providing a durable moat and stable revenue streams. U.S. expansion delivers double-digit growth, while U.K. operations stabilize post-refurbishment and European exit; Roberto Coin integration adds margin-accretive diversification.

HomeStock IdeasLong IdeasConsumer Staples Analysis

SummaryMondelēz International is rated a Buy, trading below intrinsic value with strong brands and recovery potential.MDLZ expects over $3 billion in 2025 free cash flow, despite recent declines from cocoa disruptions and weak consumer demand.Dividend yield is elevated at ~3.64%, with aggressive buybacks signaling management confidence but raising sustainability questions.Key risks include commodity price volatility, regulatory pressures, retailer private label trends, and leverage levels in a challenging macro environment. DanielBendjy/iStock Unreleased via Getty Images

Introduction & Financials Mondelez International, Inc. (MDLZ) is now trading at some of its lowest levels in more than half a decade, as the company has seen significant cocoa disruptions from tariffs and a

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in MDLZ over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Quick Insights

Recommended For You

Owning the Vanguard Mid-Cap ETF for decades could be one of the wisest financial decisions you could ever make.

Many people have the financial goal of saving $1 million (or more) for their retirement. But it's difficult to know where to get started or how to achieve such a large sum of money.

The good news that the path toward a multimillionaire portfolio isn't complicated. While accumulating that much money isn't easy, the investment strategy is straightforward: Contribute substantial sums of money every month, for many years, into an exchange-traded fund (ETF).

Here's why the Vanguard Mid-Cap ETF (VO 0.43%) is one of the best places to invest your money if you want to retire a multimillionaire without needing to pick individual stocks.

Image source: Getty Images.

You don't have to be an expert
One of the great advantages of buying the Vanguard Mid-Cap ETF is that you don't need to be an investing expert. The fund tracks the CRSP US Mid Cap Index, which consists of about 290 mid-capitalization stocks across many sectors, including energy, consumer goods, technology, finance, and others.

This means that you don't have to follow investing trends, like picking artificial intelligence stocks, shifting your investments if the economy slows down, or changing course if some new company becomes a must-have stock in your portfolio.

With the Vanguard Mid-Cap ETF, you'll have exposure to well-established companies that are in the sweet spot between generating cash flow and still being small enough for significant growth opportunities. A few examples of the top holdings in the fund are Robinhood Markets, Constellation Energy, and Roblox.

In short, if you don't have any interest in following what specific companies are doing regularly and instead want your portfolio to benefit from established companies in the market, the Vanguard Mid-Cap ETF is the way to do it.

Today's Change

(

-0.43

%) $

-1.25

Current Price

$

291.83

You can become a multimillionaire with enough time
Becoming a multimillionaire isn't easy, so I won't promise anything. But you can become a multimillionaire by investing in the Vanguard Mid-Cap ETF if you put enough money into the fund on a regular basis and invest for decades.

That's because the fund has had an average annual return of 9.95% since its inception in 2004, which is nearly on par with the average historic annual return of the S&P 500. That's an impressive return, and it can do wonders for your portfolio if you let it sit there for a long time.

Here's how much you'll need to invest on a monthly basis and for how many years to reach at least $2 million, assuming a 9.95% average annual return:

Monthly Contribution

Years to Grow

Final Amount

$5,275

15

$2 million

$2,950

20

$2 million

$1,050

30

$2 million

Calculations by author via Investor.gov.

There's no guarantee the fund will earn 9.95% each year -- sometimes it will be more and sometimes less -- but with more than two decades of those average returns, it's a pretty good indicator of the fund's long-term potential for returns.

And considering the Vanguard Mid-Cap ETF has a very low expense ratio of just 0.04% -- which equals $4 annually for every $10,000 invested -- you'll pay next to nothing in fees to own the fund.

Just remember, the key to reaching $1 million, $2 million, or whatever your personal financial goal may be is to invest regularly, stay invested through both the good times and the bad, and let your money grow over time.

About Ian Lyall
Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually.
Prior to Proactive, Ian helped lead the business output at the Daily... Read more

About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.

Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.

We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.

The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.

Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.

Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.

Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.

The EU has announced a probe into whether Google breached antitrust rules over its use of online content to train its AI.

The EU announced Tuesday it had opened a probe to assess whether Google breached antitrust rules by using content put online by media and other publishers to train and provide AI services without appropriate compensation.

The European Commission said the investigation would look into concerns that the US tech giant might be distorting competition by imposing unfair terms and conditions on publishers and content creators, or by granting itself privileged access to their output.

"A free and democratic society depends on diverse media, open access to information, and a vibrant creative landscape," the European Union's competition chief, Teresa Ribera, said.

"AI is bringing remarkable innovation and many benefits for people and businesses across Europe, but this progress cannot come at the expense of the principles at the heart of our societies."

The commission, the European Union's antitrust regulator, said the probe would focus on two issues.

It would look into whether Google used YouTube videos to train its generative AI models without adequately paying the creators who post the clips online—and without offering them the possibility to refuse such use of their content.

"Google does not remunerate YouTube content creators for their content, nor does (it) allow them to upload their content on YouTube without allowing Google to use such data," the commission said.

"At the same time, rival developers of AI models are barred by YouTube policies from using YouTube content to train their own AI models."

The probe would also check whether the firm used online content from other sites, such as newspaper websites, to provide generative AI-powered services, again with no compensation or possibility to opt-out.

This relates in particular to Google's AI-generated summaries that pop-up in response to a user's search query and to the firm's "AI Mode"—a search tab similar to a chatbot which answers users' questions, the commission said.

"We are investigating whether Google may have imposed unfair terms and conditions on publishers and content creators, while placing rival AI models developers at a disadvantage, in breach of EU competition rules," Ribera said.

There is no deadline for the commission to complete its investigation and the opening of a probe does not prejudge its outcome. The company, however, risks a hefty fine.

© 2025 AFP

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

BWM's supervisory board on Tuesday appointed Milan Nedeljkovic as the German carmaker's new CEO with effect from May 14, 2026.

TotalEnergies has struck a deal to step in as operator of Galp's Mopane offshore permit in Namibia's Orange Basin, acquiring a 40% stake from the Portuguese firm, the French oil major said on Tuesday.

Cullinan Therapeutics, Inc. (CGEM) Discusses Initial CLN-049 Results and Development Strategy for AML Applications Transcript

HomeDividends AnalysisDividend IdeasEnergy Analysis

SummaryEnbridge offers a nearly 6% dividend yield, supported by robust core infrastructure and bolt-on growth projects in North American energy markets.ENB reaffirms strong EBITDA guidance, targets 5% DCF/share growth, and maintains a 65% payout ratio, supporting its dividend aristocrat status.Significant growth opportunities stem from LNG, gas transmission, and renewables, with $3B+ in new projects and multi-billion dollar cash flow contracts with major tech firms.Key risks include ENB’s $70B debt load and exposure to oil/gas demand shifts, but current leverage remains within target, and self-funding supports ongoing returns. JHVEPhoto/iStock Editorial via Getty Images

Enbridge Inc. (ENB) is an incredibly diversified midstream company, with a market capitalization of more than $100 billion. The company has an almost 6% dividend yield, and it's spending billions of dollars on additional growth. The company is a premier provider of takeaway capacity and

Analyst’s Disclosure:I/we have a beneficial long position in the shares of ENB either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About Ian Lyall
Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually.
Prior to Proactive, Ian helped lead the business output at the Daily... Read more

About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.

Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.

We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.

The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.

Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.

Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.

Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.

Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has cleared an important hurdle in the early testing of its experimental peanut allergy treatment, saying the highest planned dose in its PROTECT study has proved safe and well tolerated.

The phase I/IIa trial has now completed dosing of the minimum required number of participants at that top dose, meeting its primary safety endpoint.

Early findings from 48 volunteers, a mix of peanut-allergic and healthy participants, showed that raising the dose 2,000-fold from the starting level did not trigger safety concerns.

VLP Peanut is designed as a short-course immunotherapy: a treatment that aims to retrain the immune system so that it reacts less aggressively to peanut proteins.

One way researchers track whether these therapies are having an effect is via skin prick tests, where a reduction in wheal size, the small swollen area that forms, can indicate a calming of the allergic response.

Earlier results from lower dose groups showed such reductions, alongside biomarker shifts seen as signs of protection, including suppressed basophil activation and rising levels of protective Ara h2 IgG antibodies.

The company said data from healthy participants also support its proposed mechanism of action.

Preliminary blinded biomarker readings taken three months after the last dose in allergic participants point to a sustained response. A second interim analysis focused on the highest doses is expected in the first quarter of 2026.

The trial is moving into a planned phase of unblinded skin prick tests and longer-term safety tracking, which will continue for up to a year after final dosing. Preparations for a Phase IIb study are underway, with dosing informed by safety and efficacy signals emerging from the current trial.

Manuel Llobet, the chief executive, said: “The PROTECT trial has now reached a key regulatory milestone with the primary safety endpoint achieved at the highest planned treatment dose.

"Safety and tolerability at these dose levels remain supportive, reinforcing our confidence in the short-course approach underpinning VLP Peanut.”

He added that the company’s focus was on using the new data to shape the next stage of development.

NUREMBERG, Germany--(BUSINESS WIRE)--NIQ (NYSE: NIQ), a leading consumer intelligence company combined with GfK in 2023, has been selected by EURONICS, a leading global shopping cooperative in the Technical Consumer Goods (TCG) sector, to provide comprehensive Online Price Monitoring. NIQ's Online Price Monitoring provides insights into pricing dynamics by tracking item-level pricing across a defined data set. The system captures product information, matches items accurately, and ensures qualit.

Company closes both LIFE and Flow Through Private Placements

VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / Star Copper Corp. (CSE:STCU)(OTCQX:STCUF)(FWB:SOP) ("Star Copper" or the "Company"), a critical minerals exploration and development company is pleased to provide a year-end summary of activities and accomplishments in addition to guidance regarding expectations for the 2026 exploration season.

Highlights

Raise of over $17 MM

Drilled 4900m in 2 phases, tested 2 new targets

11 holes still pending at assay labs

First 3 holes released (see Phase 1 Highlights)

Permit extended to 2028

Work camp and airstrip remediation completed

Achievements in 2025 were initially based upon extensive records representing $10 million in historic drilling. The recently concluded campaign successfully tested both the lateral and vertical continuity of previously identified mineralized zones along with extensive area-wide field work including mapping, soil and rock sampling. The combined results significantly extend overall geochemical and geophysical knowledge and provide important guidance for the upcoming 2026 season.

Company CEO, Daryl Jones notes, "Building off strong fundamentals, we raised over $17 million to fund a clear set of exploration objectives. Our technical team effectively reprocessed existing geophysical data to produce 3D magnetic inversion models, which produced a nested porphyry model, which in turn guided 4,900 meters of targeted drilling across two preplanned phases. A total of 13 holes were drilled, which expanded the Star Main supergene oxidized deposit to roughly 500 meters x 550 meters x 100 meters deep, demonstrated a consistent transition from supergene to hypogene mineralization below 200 meters, verified that mineralization is still open below depths of at least 500 meters, and perhaps most importantly, significantly expanded the known areas of mineralization in multiple directions up to 2.5 kilometers from the Star Main asset onwards to our Copper Creek and Star North project areas. The Company then capped off 2025 with another progressive financing which positions the Company to exit 2025 with nearly $10 million in cash on the balance sheet. All this activity packed into one exploration season truly sets the stage for an exciting year ahead."

"Looking forward to 2026," Jones continues, "the Company is planning on strengthening and delineating existing Star asset models with detailed 3D geophysical data studies to provide greater, and more accurate comprehensive analysis with the incorporation of all assay results including from pending assays from as-yet unreported holes drilled in 2025, and by attracting specialized technical and operational talent to increase and improve our ability to effectively manage the growth focused scope of the project."

Phase 1 Drill Campaign Summary (to-date)

Phase 1 drilling expanded the near-surface supergene footprint to the west and southwest, confirmed copper mineralization across multiple intrusive phases, and sharpened the structural and alteration framework-particularly along the Star Fault and associated potassic (K-feldspar) alteration corridors. The six-hole drill campaign (S-050, S-051, S-052, S-053B, S-054A, S-055) totaled over 2200m and culminated with Hole S-055 (2025-E), which intersected a near-surface oxide horizon (visible malachite and azurite) transitioning at depth to chalcopyrite in mineralized quartz monzodiorite, consistent with our oxide-to-hypogene model along major structures. With assay results still pending, the Company will take the winter months to refine the geologic model to further advance future drilling on Star. Assays results for the initial three drillholes have been completed (see news releases September 22, 2025, and September 30, 2025), with assays pending for holes S-503B, S-054A, and S-055.

Figure 1-2025 Drill Collar Locations. Star Copper 2025

Table 1 - 2025 Drill Holes

Target

Hole_ID

Easting

Northing

Elevation

Azimuth

Dip

Total Depth

Star Main

S_050

339836.6

6458308

1132.305

270

-85

101

Star Main

S_051

339766.1

6458303

1121.538

235

-85

539

Star Main

S_052

339857.6

6458405

1155.584

240

-83

674

Star Main

S-053B

339723.9

6458250

1103.396

260

-83

183

Star Main

S-055

339786.9

6458116

1045.055

270

-85

330.5

Star Main

S-054A

339992.1

6458294

1123.932

270

-85

413

Star Main

S-056

339693.4

6458145

1051.331

0

-75

551

Star Main

S-057

339693.4

6458145

1051.331

0

-88

511.25

Star Main

S-058

339704.1

6458491

1166.101

0

-90

276

Star Main

S-059

339865.2

6458454

1164.337

180

-80

317

Star Main

S-060

339928.5

6458218

1118.994

265

-85

322

Star Main

S-061

339556

6457956

941.41

320

-65

74

Copper Creek

CC-25-001

341181

6456422

901

262

-45

151

Star North

SN-25-001

340487

6459084

1163

131

-45

402

UTM Zone 9N

Highlights from Phase 1

Hole S-051 intersected 226.54m 0.70% CuEq (0.44% Cu & 0.25 g/t Au) from 14m.

Including 90m of 1.13% CuEq (0.65% Cu & 0.47 g/t Au) from 14m.

Including 40m of 1.73% CuEq (1.03% Cu & 0.68 g/t Au) from 34m.

Hole S-050 intersected 93m 0.93% CuEq (0.56% Cu & 0.36 g/t Au) from 8m.

Hole S-052 intersected 397m of 0.37% CuEq (0.25% Cu & 0.11 g/t Au) from 29m.

Including 228m of 0.51% CuEq (0.34% Cu & 0.17 g/t Au) from 17m.

Including 90.95m of 0.75 CuEq (0.51% Cu & 0.23 g/t Au) from 29m.

Samples from the Phase 1 program have all been shipped to the laboratory, and results will be reported once received and reviewed under our QA/QC protocols. The supergene zone continues to deliver the most exciting early visuals, giving confidence that this could be a potentially large oxide footprint (See inset photo Figures 2 & 3). With the Star project holding vast potential in the supergene zone, the Company is extremely excited about the hypogene mineralization which continues northwest and southeast of the supergene with a footprint of 1 km long by 500 m wide. The hypogene system also extends well below the 100m depth to well over 400m as reported in the first 3 holes from Phase 1.

Figure 2-Supergene mineralization in S-051 42.0-42.26m. Star Copper 2025

Figure 3-Azurite and malachite mineralization in lower trench beside collar of S-061
as 20 cm long angular subcrop. Star Copper 2025.

Phase 2 Drill Campaign Summary (to date)

Phase 2 wrapped up mid-November with a total of 2,700 m spread over the Star Main deposit, Star North and Copper Creek targets. The drilling was successful in confirming that both Star North and Copper Creek showed valuable visible chalcopyrite and strong mineralization that will be followed up in 2026 drilling (see Figure 5).

Star Main drilling in Phase 2 centered around the relationship between supergene to hypogene transition and the structures that carry the mineralization. Copper Creek is a historically drilled target 2.2 km Southeast of the Star Main deposit and has a very strong soil signature associated with a coincident chargeability high similar to Star Main. One hole was drilled to a depth of 120 m and intersected strong VMS mineralization over a broad intercept at the target depth. Star North, which is another strong soil anomaly and coincidental chargeability high, located 1 km northeast of the Star Main saw 400m of drilling to test the structure to allow for further drilling to expand the target in 2026. Star Main also saw additional follow up drilling during phase 2 to confirm the hypogene mineralization and expand the overall deposit model. A total of 13 holes were drilled at Star Main with 11 assays still pending.

Figure 4-Star Project Overview. Star Copper 2025.

Figure 5-Copper Creek Mineralization at 120m (Drill hole CC-25-001). Star Copper 2025.

In Conclusion

The Company is now compiling all relevant work completed in the field in 2025 to better understand the deposit model on Star Main and develop the model for Star North and Copper Creek. With a very successful 2025 drill season concluded, the Company is tremendously excited about the prospects for the 2026 campaign. The Company looks forward to commencing fieldwork early in 2026 to undertake additional drilling, additional 3D geophysics and related data compilation to continue growing our value proposition to meet the expectations of our team members, stakeholders and shareholders as we strive towards affirming Star Copper holds Canada's next big copper deposit.

Key takeaways

Robust deposit model showing transition from supergene to hypogene intact

Mineralization continues to 500m, and open at depth

Robust drill target pipeline for 2026 field work

Deep 3D geophysical modelling planned to enhance deposit model

Assays still pending for 11 holes

Well-funded to open camp and begin 2026 field season

To find out more, visit our website and watch our videos at https://starcopper.com/media/.

Private Placement Closings

Further to the Company's announcements of November 20, 2025 and November 25, 2025, the Company is also please to announce the completion of two non-brokered private placements:

Non-Brokered LIFE Private Placement

The Company has completed a non-brokered private placement for gross proceeds of C$3,000,000 from the sale of 3,000,000 units of the Company (each, a "Unit", and collectively, the "Units") at a price of C$1.00 per Unit (the "LIFE Offering") under the Listed Issuer Financing Exemption (as defined herein). Each Unit consists of one common share (each, a "Share" and collectively, the "Shares") and one common share purchase warrant (each a "Warrant" and collectively, the "Warrants"). Each Warrant is exercisable to acquire one common share (each a "Warrant Share", and collectively, the "Warrant Shares") at a price of $1.20 per Warrant Share for a period of 24 months from the date hereof (the "Closing Date"). The Warrants are not listed for trading on any stock exchange.

Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 - Prospectus Exemptions ("NI 45-106"), the LIFE Offering was made to purchasers resident in all provinces of Canada, except Quebec, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the "Listed Issuer Financing Exemption"). The securities offered under the LIFE Offering pursuant to the Listed Issuer Financing Exemption are not subject to resale restrictions pursuant to Canadian securities laws. There is an offering document dated November 20, 2025 (the "Offering Document") related to the LIFE Offering that can be accessed under the Company's issuer profile on SEDAR+ at www.sedarplus.ca and on the Company's website at: www.starcopper.com.

The gross proceeds of the LIFE Offering will be used for general corporate and working capital purposes, which may include investor relations activities.

The Company paid finder's fees in connection with subscriptions to the LIFE Offering totalling $22,750 cash, and 22,750 broker's warrants (each a "Broker Warrant" and collectively the "Broker Warrants"). Each Broker Warrant was issued on the same terms as the Warrants, but for that the Broker Warrants are non-transferable.

Non-Brokered Flow Through Private Placement

The Company has also completed a non-brokered private placement for gross proceeds of C$2,499,300.18 from the sale of 2,118,051 "flow-through" units of the Company (each, an "FT Unit", and collectively, the "FT Units") at a price of C$1.18 per FT Unit (the "FT Offering"). The FT Offering was not completed under the Listed Issuer Financing Exemption.

Each FT Unit consists of one "flow-through" common share (each, an "FT Share" and collectively, the "FT Shares") and one "flow-through" common share purchase warrant (each an "FT Warrant" and collectively, the "FT Warrants"), issued as "flow-through shares", as defined in subsection 66(15) of the Income Tax Act (Canada) (the "Tax Act"). Each FT Warrant is exercisable to acquire one common share (each a "Warrant Share", and collectively, the "Warrant Shares") at a price of $1.20 per Warrant Share for a period of 24 months from the Closing Date. The Warrant Shares underlying the FT Units will not qualify as "flow-through shares" under the Tax Act. The FT Warrants to be issued pursuant to the FT Offering are not listed for trading on any stock exchange.

The gross proceeds of the FT Offering will be used to incur "Canadian exploration expenses" that are "flow-through critical mineral mining expenditures", within the meaning of the Tax Act, on the Company's flagship Star Project.

The Company paid finder's fees in connection with subscriptions to the FT Offering totalling $174,951.01 cash, and 148,264 broker's warrants (each a "FTBroker Warrant" and collectively the "FTBroker Warrants"), representing 7% of the gross proceeds and number of FT Units issued, respectively. Each FT Broker Warrant was issued on the same terms as the FT Warrants, but for that (i) the FT Broker Warrants are non-transferable and (ii) the FT Broker Warrants were not issued as "flow through shares" as defined in subsection 66(15) of the Tax Act.

QA/QC Statement

Star Copper Corp. follows industry standard protocols for diamond drilling and quality assurance/quality control (QA/QC) procedures in British Columbia. All drilling is carried out using HQ and NQ sized diamond drill core. Drill core is transported from the drill site to a secure core logging facility where it is logged, photographed, and sampled under the supervision of geologists. Core is cut in half using a diamond saw, with one half of the core placed in a sealed sample bag and sent for analysis, and the other half retained on site for reference and further studies.

Samples are shipped under chain-of-custody protocols to Bureau Veritas Laboratories, an ISO/IEC 17025 accredited laboratory. At Bureau Veritas, samples are dried, crushed, split, and pulverized to 85% passing 200 mesh. Analytical procedures include multi-element ICP-ES/MS following four-acid digestion, with gold and precious metals analyzed by fire assay with an atomic absorption or ICP finish.

Star Copper implements a robust QA/QC program, including the insertion of a minimum 5% certified reference materials (standards), blanks, and field duplicates at regular intervals into the sample stream to monitor analytical accuracy and precision. The performance on the blind standards, blanks and duplicates achieved high levels of accuracy and reproducibility and has been verified by Jeremy Hanson, a qualified person as defined by NI-43-101.

Qualified Person

Jeremy Hanson, P. Geo., a Qualified Person as that term is defined under NI 43-101, is an independent contractor of the Company and has reviewed and approved the technical aspects of this news release.

On Behalf of the Board of Directors

~Darryl Jones~

Darryl Jones
CEO, President & Director
Star Copper Corp.

About Star Copper Corp. (CSE:STCU)(OTCQX:STCUF)(FWB: SOP) (WKN A416ME)

Star Copper Corp. is an exploration and development company focused on developing high-potential copper projects in mining-friendly jurisdictions. The Company aims to advance its 100%-owned Star Project in British Columbia's prolific Golden Triangle and Sheslay District (watch our videos https://starcopper.com/media/). The project hosts multiple copper-gold porphyry-style targets, including Star Main, Star North, and Copper Creek. Significant exploration including historical drilling has confirmed open mineralization at depth and in all directions. Star Copper's strategic plans include geological mapping and geophysical surveys to refine existing targets,diamond drilling programs to test high-priority zones, environmental baseline studies and permitting groundwork alongside data analysis and resource modeling to support a future resource estimate prepared in accordance with NI 43-101. The Company further plans to advance its Indata Project with follow-up drilling to expand on previous high-grade copper and gold intercepts, trenching and surface sampling to delineate mineralized zones, and infrastructure improvements for site accessibility and operations. With a commitment to sustainable development and value creation, Star Copper aims to position itself to support surging industrial demand to meet growing global electrification needs.

For more information visit: www.starcopper.com to watch our selection of videos at https://starcopper.com/media/, and while you are there, sign up for free news alerts at https://starcopper.com/news/news-alerts/or follow us on X (formerly Twitter),Facebook or LinkedIn. More information regarding the project, including historical drilling, is available under the Company's profile at www.sedarplus.ca and/or in the Company's February 26, 2025 technical report.

Investor Relations
Star Copper Corp.
Email: [email protected]
Web: https://starcopper.com/

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this news release are forward-looking statements that involve risks and uncertainties. Forward-looking statements in this press release include, but are not limited to, statements regarding exploration of the Company's ‘Star Project' and the potential thereof, the use of proceeds from both the LIFE Offering and FT Offering, as well as the anticipated mineral resource estimate planned in respect of the Star Project. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include, but are not limited to, the early-stage nature of the Star Project, the inherently unpredictable nature of resource exploration, market conditions and the risks detailed from time to time in the filings made by the Company with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect, and actual results may differ materially from those anticipated. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

SOURCE: Star Copper Corp.

AutoZone, Inc. (NYSE:AZO) will release earnings results for the first quarter before the opening bell on Tuesday, Dec. 9.

Analysts expect the company to report quarterly earnings at $32.51 per share, down from $32.52 per share in the year-ago period. The consensus estimate for AutoZone's quarterly revenue is $4.64 billion. Last year, it reported $4.28 billion in revenue, according to Benzinga Pro.

The company reported a growth of 6.9% in its sales during the fourth quarter. It also reported a 7.8% decrease in operating profit to $1.2 billion, while the company’s EPS was down to $48.71 from $51.58, a 5.6% decrease.

Shares of AutoZone fell 1.5% to close at $3,766.96 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

Goldman Sachs analyst Kate McShane upgraded the stock from Neutral to Buy and cut the price target from $4,090 to $4,262 on Dec. 5, 2025. This analyst has an accuracy rate of 67%.
BMO Capital analyst Tristan Thomas-Martin maintained the stock with an Outperform rating and raised the price target from $4,100 to $4,600 on Sept. 25, 2025. This analyst has an accuracy rate of 64%.
Truist Securities analyst Scot Ciccarelli maintained the stock with a Buy and lowered the price target from $4,504 to $4,499 on Sept. 24, 2025. This analyst has an accuracy rate of 71%.
Raymond James analyst Bobby Griffin maintained the stock with a Strong Buy and cut the price target from $4,900 to $4,800 on Sept. 24, 2025. This analyst has an accuracy rate of 71%.
Morgan Stanley analyst Simeon Gutman maintained the stock with an Overweight rating and raised the price target from $4,000 to $4,700 on Sept. 24, 2025. This analyst has an accuracy rate of 68%
Considering buying AZO stock? Here’s what analysts think:

Read This Next:

Top 3 Materials Stocks That Are Preparing To Pump In Q4
Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Ford and Renault are setting up a new production strategy in Europe as competition from Chinese electric carmakers intensifies.

Both companies face cost pressures and market shifts that are changing how vehicles are made across the region.

Their plan focuses on shared platforms, cheaper development cycles, and flexible output as the European Union prepares updates on future engine rules later this month.

The partnership comes at a time when many manufacturers are reworking their electric vehicle plans in response to slow charging expansion, high production costs, and strong demand for lower-priced models from both European and Chinese brands.

New push for affordable EVs
Copy link to section

Renault will develop and produce two Ford-branded models in northern France, with the first expected to reach showrooms in early 2028.

Both firms also intend to explore joint van manufacturing.

The cooperation gives Ford access to Renault’s lower-cost EV development processes, including work done in Shanghai for the electric Twingo, which is due next summer and expected to be priced below €20,000, or $23,299.

Europe shifts strategy amid Chinese expansion
Copy link to section

Car manufacturers in Europe are under pressure as Chinese brands such as BYD expand with low-cost electric and hybrid vehicles.

European companies are also adopting Chinese engineering know-how to reduce costs and shorten production timelines.

This shift is reshaping the competitive landscape across the region and affecting long-term investment decisions for legacy brands.

Ford trims its European footprint
Copy link to section

Ford’s market share in Europe has shrunk from more than 7% a decade ago to just over 3%.

The company has been cutting output and jobs, signalling a smaller operational presence.

At its Cologne plant, where it produces electric vehicles on a Volkswagen platform, Ford will move to a single production line in 2026 after announcing workforce reductions in September.

Production has already ended in Saarlouis, showing a broader shift toward partnerships rather than maintaining a full standalone manufacturing base.

Industry reacts to policy uncertainty
Copy link to section

European carmakers are adjusting their electric plans after early strategies stumbled due to limited charging infrastructure and higher-than-expected costs.

Policymakers in Brussels may revise the planned 2035 phase-out of combustion engine car sales, following industry claims that consumers are switching to EVs more slowly than predicted.

At the same time, the region is seeing a rise in state-supported EV imports from China.

Other brands are also redirecting their efforts toward affordable models.

Stellantis increased output of Citroëns in November due to strong demand for the C3 city car, while Volkswagen is preparing budget options such as the ID. Polo, is expected to be priced below €25,000 next year.

Ford and Renault are also planning shared van production as part of this broader focus on cost efficiency.

VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is advancing the development of a next-generation "Melt in Your Mouth" cladribine formulation, built on the Company's proprietary oral dissolvable film (ODF) drug-delivery system. The technology is designed for rapid, sublingual (under-the-tongue) absorption of medication and aims to improve treatment access and comfort for people living with multiple sclerosis (MS). BioNxt's lead program, BNT23001, is being developed as a swallow-free alternative to cladribine tablets, which generated USD 1.28 billion in global sales in 2024.

Cladribine (Mavenclad®) is an established therapy for MS; however, many patients struggle with difficulty swallowing tablets, a symptom that is both common and often under-recognized. For these individuals, pill-based medication can lead to coughing, choking, anxiety, and missed doses - all of which reduce treatment consistency and therapeutic effectiveness.

BioNxt's "Melt in Your Mouth" ODF is engineered to dissolve in seconds under the tongue, eliminating the need to swallow and offering a needle-free, patient-friendly method of administration. The approach aims to enhance treatment adherence, safety, and overall quality of life for MS patients who face challenges with tablet-based medication.

Swallowing Difficulties: A Hidden Barrier in Multiple Sclerosis Treatment

Swallowing problems (dysphagia) are common in MS but often overlooked. A recent meta-analysis of more than 10,800 MS patients found that approximately 45% experience dysphagia during the course of their disease (2023, Journal of Clinical Neuroscience). Additional clinical studies using instrumental swallowing assessments have reported abnormalities in over 50% of patients, including cases not detected through self-report.

For these individuals, tablets may feel "stuck," provoke coughing or choking, or require repeated attempts to swallow - turning a simple daily task into a persistent source of stress.

As swallowing becomes more difficult or unsafe, patients may delay doses, avoid medication altogether, or require caregiver assistance. By removing the need to swallow, BioNxt's "Melt in Your Mouth" cladribine ODF is being developed specifically to address this barrier and help maintain consistent, safe access to cladribine therapy.

Significant Market Opportunity for a Patient-Friendly Cladribine Format

The global cladribine market is expanding rapidly. Merck KGaA's cladribine tablets (Mavenclad®) generated over USD 950 million in the first three quarters of 2025, reflecting strong, ongoing demand across the U.S. and Europe. The company reported record quarterly sales in 2025 and continues to expect growth in Europe, although a recent U.S. patent decision could open the door to generic competition beginning in 2026.

According to Cladribine Market Research Report 2033 from Dataintelo, the global cladribine market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.5 billion by 2032, representing a robust 8.5% CAGR driven by rising MS prevalence and interest in innovative drug-delivery formats.

At the same time, the oral transmucosal drug-delivery market - including sublingual and buccal systems - is expected to grow from USD 45.8 billion in 2025 to nearly USD 96.8 billion by 2033. As a low-dose molecule well suited to BioNxt's Melt in Your Mouth ODF technology, cladribine sits at the intersection of two fast-growing global markets, offering a significant opportunity to modernize and differentiate an established therapy.

"Taking a tablet should not be a barrier to treatment," said Hugh Rogers, CEO of BioNxt Solutions. "Our Melt in Your Mouth cladribine film is designed specifically for MS patients who struggle to swallow pills. We are addressing a meaningful unmet need by making an important therapy easier, safer, and more accessible in everyday life."

About BioNxt Solutions Inc.

BioNxt Solutions Inc. is a bioscience innovator focused on next‐generation drug delivery technologies, diagnostic screening systems, and active pharmaceutical ingredient development. The Company's proprietary platforms-Sublingual (Thin‐Film), Transdermal (Skin Patch), and Oral (Enteric‐Coated Tablets)-target key therapeutic areas, including autoimmune diseases, neurological disorders, and longevity.

With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, primarily focused on European markets. BioNxt is committed to improving healthcare by delivering precise, patient‐centric solutions that enhance treatment outcomes worldwide.

BioNxt is listed on the Canadian Securities Exchange: BNXT, OTC Markets:BNXTF and trades in Germany under WKN: A3D1K3. To learn more about BioNxt, please visit www.bionxt.com.

Investor Relations & Media Contact

Hugh Rogers, Co‐Founder, CEO and Director
Email: [email protected]
Phone: +1 778.598.2698

Web: www.bionxt.com
LinkedIn: https://www.linkedin.com/company/bionxt‐solutions
Instagram: https://www.instagram.com/bionxt

Cautionary Statement Regarding "Forward‐Looking" Information

This news release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Forward-looking information in this news release includes the anticipated filing date of the Annual Filings. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include regulatory actions, market prices, and continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

SOURCE: BioNxt Solutions Inc.

The European Commission has opened an antitrust probe to assess whether Google is breaching EU competition rules in its use of online content from web publishers and Youtube for artificial intelligence purposes, it said on Tuesday.

UPPSALA, SE / ACCESS Newswire / December 9, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ.) today announced that one of the leading NHS hospital trusts in the United Kingdom (UK) has ordered a total of 70 TetraGraph systems to standardize neuromuscular monitoring across all major operating rooms. The contract was secured by Senzime's partner in the UK, Healthcare 21, and annual usage is expected to exceed 15,000 TetraSens sensors at full implementation.

The National Health Service (NHS) is the publicly funded healthcare system in the UK. It is divided into more than 200 NHS trusts, including over 1,000 hospitals and approximately 3,000 operating rooms.

"This is a strategic win for us in the UK market and a clear signal that the NHS is accelerating the transition to the latest advancements in neuromuscular monitoring. It's our single largest TetraGraph order received to date in Europe, serving as an excellent reference for broader expansion. As UK guidelines strongly mandate the use of quantitative monitoring, we see significant momentum ahead and are proud to support safer anesthesia care for patients across the country", said Philip Siberg, CEO of Senzime.

The guidelines issued by the Association of Anaesthetists of Great Britain and Ireland (AAGBI) state that quantitative monitoring is essential and should be available in every operating theatre across the UK and Ireland. The guidelines further recommend using quantitative monitoring whenever neuromuscular blocking (NMB) drugs are administered, throughout all phases of anesthesia - from initiation of neuromuscular blockade until full recovery.

Senzime's TetraGraph system is used in thousands of operating rooms at university, public, private, military and veterans' hospitals worldwide to enhance patient safety before, during and after surgery. By accurately monitoring neuromuscular function in real time, TetraGraph supports safe timing of intubation, individualized dosing of paralytic and reversal agents, and proper timing of tracheal extubation, ensuring safe return to spontaneous breathing after surgery.

For further information, please contact:

About Senzime

Senzime is a leading medical device company at the forefront of a changing healthcare market, driven by new clinical guidelines and emerging technologies. Established in 1999, Senzime develops and markets precision-based monitoring systems that improve outcomes, reduce costs, and advance perioperative patient safety. The flagship solution is the TetraGraph® system, proven best-in-class for accurate monitoring of neuromuscular transmission during surgery and used in thousands of operating rooms across the globe. The system helps to secure precise dosing of paralytic drugs and provides enhanced insights to safeguard every patient's journey, from anesthesia to recovery.

Headquartered in Uppsala, Sweden, Senzime is publicly traded on the Nasdaq Stockholm Main Market (SEZI), with cross-trading on the US OTCQX Market (SNZZF), and backed by long-term investors. More information is available at senzime.com.

Attachments

Senzime secures major TetraGraph order from leading UK NHS hospital system

SOURCE: Senzime

About Ian Lyall
Ian Lyall, a seasoned journalist and editor, brings over three decades of experience to his role as Managing Editor at Proactive. Overseeing Proactive's editorial and broadcast operations across six offices on three continents, Ian is responsible for quality control, editorial policy, and content production. He directs the creation of 50,000 pieces of real-time news, feature articles, and filmed interviews annually.
Prior to Proactive, Ian helped lead the business output at the Daily... Read more

About the publisher
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.

Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.

We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.

The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.

Use of technology
Proactive has always been a forward looking and enthusiastic technology adopter.

Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.

Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.